Accelerating the Implementation of Mass Spectrometry in the Clinical Lab




View Congress Program

1st Annual Conference & Exhibits

Salzburg Congress Center

Salzburg, AUSTRIA

September 2-5, 2014

Plenary Presentations

>> Thursday 8:15 AM @ Mozart Hall
Direct Mass Spectrometric Characterization of Fluids, Cells and Tissues - The Benefits and the Price of Real-Time Analysis
Zoltan Takats
Imperial College London

Development of ambient mass spectrometric techniques opened a new way of looking at clinical samples regarding the simplicity (and time demand) of analysis and the nature of data produced by these techniques. Application of these approaches in cancer surgery, histopathology, clinical microbiology and clinical chemistry has been successfully demonstrated. While these techniques mean valid alternatives to currently used technologies - with clear benefit on both cost and reliability sides - their widespread application can potentially change the current landscape of medical diagnostics. Future role of these methods in stratified clinical patient journeys will be discussed with particular emphasis on the currently unresolved problems and their future solutions regarding both regulatory and technology aspects.

>> Thursday 9:00 AM @ Mozart Hall
Metabolism and Disease Pathogenesis
Gary Siuzdak
The Scripps Research Institute

Our lab focuses on the quantitative global analysis of endogenous metabolites (metabolomics) and the role these molecules play in disease pathogenesis. While the genome and proteome represent upstream biochemical events, metabolites correlate with the most downstream biochemistry and therefore most closely represent the phenotype. The experimental aim in our studies is to obtain a comprehensive view of the metabolome to expand our understanding of what pathways are altered in disease. We have developed a novel web-based platform for metabolomics that includes XCMS Online data analysis combined with METLIN, a comprehensive MS/MS metabolite database, as well as Nanostructure Imaging Mass Spectrometry (NIMS). These technologies will be presented in the context of pain and colorectal cancer.

>> Thursday 6:30 PM @ Mozart Hall
The Impact and Potential Consequences of Machine Intelligence on Healthcare
Randall Julian
Indigo BioSystems, Inc.

Intelligent machines teamed with experts are superior to experts working alone. This will have profound effects on the nature of healthcare delivery. Further, the advance of automation is already having a significant effect on labor markets, and there is no reason to believe healthcare will not be impacted. In this lecture examples of human-machine teams will be given. Also, the impact on society of the increased role of smart machines will be discussed. Comparisons between the first and second machine ages will be used to draw out the consequences, benefits and difficulties we will face as a scientific community.

>> Friday 8:15 AM @ Mozart Hall
MALDI-TOF in Medical Microbiology
Irene Burckhardt
UniversitätsKlinikum Heidelberg, Dept for Infectious Diseases

Bacterial identification via MALDI-TOF has become state of the art during the last years. For susceptibility testing different very promising assays have been proposed. However, to routinely generate MALDI-TOF data for a complete antibiogram as we know it from agar diffusion or MIC determination is still not possible. To miniaturize these assays and to integrate them into a total lab automation will be the key tasks for the coming years.

>> Friday 9:00 AM @ Mozart Hall
High Resolution Proteomics for Clinical Applications
Matthias Mann
Max-Planck Institute of Biochemistry

Mass spectrometry based proteomics has advanced tremendously in the last few years. We describe a shotgun proteomics workflow that allows us to detect and quantify the large majority of the proteins expressed in a biological system such as cancer cell lines. This included streamlined and highly efficient sample preparation, analysis with very high sequencing speed using modern mass spectrometers and bioinformatic analysis using the MaxQuant and Perseus platforms. Efforts in our group have focused on ‘single shot’ analysis and we demonstrate very high coverage in this mode (Mann et al., 2013). In this talk, I will focus on applications of proteomics to questions of clinical relevance.

Program Description

MSACL EU is an off-shoot of the highly successful MSACL US conference that has been held in San Diego since 2008. The conference provides a forum for discussing the clinical application of mass spectrometry by bringing together academic and industrial experts in the field with those driven to explore and understand more about the potential application and benefits. The mission of MSACL is to accelerate the implementation of mass spectrometry in the clinical laboratory to the end effect improved patient standard-fo-care and reduced health care costs.

MSACL invests a significant amount of resources in education via the MSACL Travel Awards, which support conference attendance:

  1. Young Investigator Awards: Young investigators, in the first four years of their academic position, who submit an abstract which is accepted for presentation (poster/podium) at the annual conference. Applicants must submit a short application.
  2. Trainee Awards: Lab Directors-to-be interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.

It's the abstracts that make the meeting. If you are working in clinical mass spectrometry and have compelling research, submit your abstract for presentation at the MSACL EU Conference.

MSACL focuses on topics including pain management, microbiology, toxicology, proteomics, metabolomics, tissue imaging, and regulations and standards. A comprehensive list is below. Let us know if there is another topic area that you think should be added.

Expected Topics for MSACL 2014 EU

*Note: Abstracts are solicited for the topics listed below, however, if no abstracts are submitted and accepted on any given topic then it will not be covered at the conference.

  1. Disease Markers
  2. Fundamentals : General
  3. Fundamentals : Metabolomics
  4. Fundamentals : Microbiolgy
  5. Fundamentals : Proteomics
  6. ICP-MS
  7. Imaging
  8. Inborn Errors of Metabolism
  9. Metabolomics
  10. Microbiology/Virology
  11. Molecular Diagnostics
  12. New Advances
  13. Occupational and Environmental Health
  14. Pain Management
  15. Proficiency Testing
  16. Proteomics
  17. Regulations & Standards
  18. Sample Prep & Automation
  19. Small Molecule Analytes
  20. Tissue Analysis
  21. Tobacco Exposure
  22. Toxicology
  23. Translational Mass Spec
  24. Various OTHER

Target Audience

The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.